Prostate specific antigen production by breast tumors after induction with oral contraceptives.

[1]  E. Diamandis,et al.  Frequent detection of mutations in the 5' flanking region of the prostate-specific antigen gene in female breast cancer. , 1997, European journal of cancer.

[2]  E. Diamandis,et al.  Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer. , 1997, British Journal of Cancer.

[3]  J. Trapman,et al.  An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. , 1997, Molecular endocrinology.

[4]  E. Diamandis,et al.  Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. , 1996, Clinical chemistry.

[5]  J. D. Miller,et al.  Prostate-specific Antigen Expression Is Regulated by an Upstream Enhancer (*) , 1996, The Journal of Biological Chemistry.

[6]  P. Sismondi,et al.  Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. , 1995, Cancer research.

[7]  E. Diamandis,et al.  New biological functions of prostate-specific antigen? , 1995, The Journal of clinical endocrinology and metabolism.

[8]  E. Diamandis,et al.  Oral Contraceptive-induced Expression of Prostate-specific Antigen in the Female Breast (*) , 1995, The Journal of Biological Chemistry.

[9]  E. Diamandis,et al.  Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. , 1994, Clinical biochemistry.